Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST). (Q34327861)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST). |
scientific article |
Statements
1 reference
Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST). (English)
1 reference
Anderson JL
1 reference
Platia EV
1 reference
Hallstrom A
1 reference
Henthorn RW
1 reference
Buckingham TA
1 reference
Carlson MD
1 reference
Carson PE
1 reference
1 December 1994
1 reference
Identifiers
1 reference